.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Johnson and Johnson
McKinsey
Express Scripts
Healthtrust
Harvard Business School
Farmers Insurance
Dow
Cipla
Teva

Generated: June 28, 2017

DrugPatentWatch Database Preview

Technetium tc-99m ferpentetate kit - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for technetium tc-99m ferpentetate kit and what is the scope of technetium tc-99m ferpentetate kit freedom to operate?

Technetium tc-99m ferpentetate kit
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m ferpentetate kit.

Summary for Generic Name: technetium tc-99m ferpentetate kit

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Clinical Trials: see list541
Drug Prices:see low prices
DailyMed Link:technetium tc-99m ferpentetate kit at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
RENOTEC
technetium tc-99m ferpentetate kit
INJECTABLE;INJECTION017045-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Teva
Cerilliant
AstraZeneca
Express Scripts
Accenture
Harvard Business School
McKesson
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot